Recent changes

Jump to: navigation, search

Track the most recent changes to the wiki on this page.

Recent changes options
Legend:
N
This edit created a new page (also see list of new pages)
m
This is a minor edit
b
This edit was performed by a bot
(±123)
The page size changed by this number of bytes
Show last 50 | 100 | 250 | 500 changes in last 1 | 3 | 7 | 14 | 30 days
Hide registered users | Hide anonymous users | Hide my edits | Show bots | Hide minor edits
Show new changes starting from 04:40, 23 August 2019
   

22 August 2019

 m   22:31  Follicular lymphoma‎ (diff | hist) . . (+973). . Jwarner (talk | contribs) (Rituximab monotherapy {{#subobject:ea91fc|Regimen=1}})
 m   22:26  Rituximab (Rituxan)‎ (diff | hist) . . (-8). . Jwarner (talk | contribs) (Also known as)
 m   22:21  Small cell lung cancer‎ (diff | hist) . . (+709). . Jwarner (talk | contribs) (Cisplatin & Etoposide {{#subobject:ec90cd|Regimen=1}})
     16:58  Breast cancer‎‎ (4 changes | history) . . (+7,487). . [Jwarner‎ (4×)]
 m    16:58 (cur | prev) . . (+2,666). . Jwarner (talk | contribs)
      13:39 (cur | prev) . . (+2,541). . Jwarner (talk | contribs) (Cyclophosphamide monotherapy {{#subobject:fb7cyd|Regimen=1}})
 m    13:25 (cur | prev) . . (+1,095). . Jwarner (talk | contribs) (Vinorelbine monotherapy {{#subobject:5c104c|Regimen=1}})
      11:19 (cur | prev) . . (+1,185). . Jwarner (talk | contribs) (Paclitaxel & Bevacizumab {{#subobject:ab5252|Regimen=1}})
 m   15:55  Breast cancer - historical‎‎ (2 changes | history) . . (-2,102). . [Jwarner‎ (2×)]
 m    15:55 (cur | prev) . . (-1,117). . Jwarner (talk | contribs) (Paclitaxel monotherapy, q3wk {{#subobject:1cb87f|Regimen=1}})
 m    15:45 (cur | prev) . . (-985). . Jwarner (talk | contribs) (Paclitaxel monotherapy, q3wk {{#subobject:1cb87f|Regimen=1}})
     15:08  Breast cancer, HER2-positive‎‎ (2 changes | history) . . (+3,278). . [Jwarner‎ (2×)]
      15:08 (cur | prev) . . (+1,212). . Jwarner (talk | contribs) (Lapatinib & Trastuzumab {{#subobject:9be4d2|Regimen=1}})
      08:55 (cur | prev) . . (+2,066). . Jwarner (talk | contribs) (Pertuzumab & Trastuzumab {{#subobject:b1d7b1|Regimen=1}})
     08:20  Breast cancer, ER/PR-positive‎ (diff | hist) . . (+1,638). . Jwarner (talk | contribs) (Anastrozole & Goserelin {{#subobject:6e3249|Regimen=1}})

21 August 2019

     22:18  Breast cancer, ER/PR-positive‎ (diff | hist) . . (+1,405). . Jwarner (talk | contribs) (Anastrozole & Fulvestrant {{#subobject:ae2512|Regimen=1}})
     22:12  Breast cancer, HER2-positive‎‎ (2 changes | history) . . (+1,628). . [Jwarner‎ (2×)]
      22:12 (cur | prev) . . (+1,368). . Jwarner (talk | contribs) (Pertuzumab & T-DM1 {{#subobject:ffffbc|Regimen=1}})
 m    14:11 (cur | prev) . . (+260). . Jwarner (talk | contribs)
     19:37  Esophageal cancer‎‎ (3 changes | history) . . (+3,563). . [Jwarner‎ (3×)]
      19:37 (cur | prev) . . (+1,811). . Jwarner (talk | contribs) (Ramucirumab monotherapy {{#subobject:425b15|Regimen=1}})
      19:34 (cur | prev) . . (+1,747). . Jwarner (talk | contribs) (Irinotecan & Mitomycin {{#subobject:dfc95f|Regimen=1}})
 m    14:32 (cur | prev) . . (+5). . Jwarner (talk | contribs) (Chemotherapy)
 m   15:08  Small cell lung cancer - historical‎‎ (3 changes | history) . . (+114). . [Jwarner‎ (3×)]
 m    15:08 (cur | prev) . . (+31). . Jwarner (talk | contribs) (Regimen {{#subobject:b2c397|Variant=1}})
 m    15:08 (cur | prev) . . (0). . Jwarner (talk | contribs) (CEV (Carboplatin/Etoposide) {{#subobject:ec321a|Regimen=1}})
 m    15:07 (cur | prev) . . (+83). . Jwarner (talk | contribs) (TEC {{#subobject:8703fa|Regimen=1}})
 m   14:36  Multiple myeloma, relapsed/refractory‎ (diff | hist) . . (+5). . Jwarner (talk | contribs) (Chemotherapy)
 m   14:36  Allogeneic HSCT‎ (diff | hist) . . (+1). . Jwarner (talk | contribs)
 m   14:33  Peripheral T-cell lymphoma‎ (diff | hist) . . (+5). . Jwarner (talk | contribs)
 m   14:33  Diffuse large B-cell lymphoma‎ (diff | hist) . . (+5). . Jwarner (talk | contribs)
 m   11:36  Ovarian cancer‎ (diff | hist) . . (-24). . Jwarner (talk | contribs) (Paclitaxel, nanoparticle albumin-bound monotherapy {{#subobject:3eae7f|Regimen=1}})
 m   11:36  Melanoma‎ (diff | hist) . . (-24). . Jwarner (talk | contribs)
 m   11:34  Pancreatic cancer‎ (diff | hist) . . (-24). . Jwarner (talk | contribs)
 m   11:34  Gastric cancer‎ (diff | hist) . . (+14). . Jwarner (talk | contribs)
 m   11:31  Bladder cancer‎ (diff | hist) . . (-19). . Jwarner (talk | contribs) (Paclitaxel, nanoparticle albumin-bound monotherapy {{#subobject:fec6dd|Regimen=1}})
 m   11:30  Breast cancer‎ (diff | hist) . . (-499). . Jwarner (talk | contribs)
 m   11:06  Uveal melanoma‎ (diff | hist) . . (-12). . Jwarner (talk | contribs) (TACE monotherapy {{#subobject:f96a1b|Regimen=1}})
 m   11:06  Hepatocellular carcinoma‎ (diff | hist) . . (-24). . Jwarner (talk | contribs)

20 August 2019

 m   16:54  Melanoma‎ (diff | hist) . . (+637). . Jwarner (talk | contribs) (Talimogene laherparepvec monotherapy {{#subobject:PYR1|Regimen=1}})
 m   16:51  Hepatocellular carcinoma‎‎ (2 changes | history) . . (+1,369). . [Jwarner‎ (2×)]
 m    16:51 (cur | prev) . . (+697). . Jwarner (talk | contribs) (Sorafenib monotherapy {{#subobject:b38f69|Regimen=1}})
 m    16:47 (cur | prev) . . (+672). . Jwarner (talk | contribs) (TACE monotherapy {{#subobject:f96a1b|Regimen=1}})
 m   16:34  Follicular lymphoma‎ (diff | hist) . . (+1,364). . Jwarner (talk | contribs) (Rituximab monotherapy, extended course {{#subobject:e26b69|Regimen=1}})
 m   16:23  Colon cancer‎‎ (3 changes | history) . . (+1,164). . [Jwarner‎ (3×)]
 m    16:23 (cur | prev) . . (+10). . Jwarner (talk | contribs)
 m    16:22 (cur | prev) . . (+1,123). . Jwarner (talk | contribs) (Tegafur, Uracil, Folinic acid {{#subobject:5ed2aa|Regimen=1}})
 m    16:19 (cur | prev) . . (+31). . Jwarner (talk | contribs) (Placebo)
 m   13:46  Head and neck cancer‎ (diff | hist) . . (+1,506). . Jwarner (talk | contribs) (Radiation therapy {{#subobject:571927|Regimen=1}})
 m   11:59  Non-small cell lung cancer‎ (diff | hist) . . (+913). . Jwarner (talk | contribs) (Carboplatin & Gemcitabine {{#subobject:8669e|Regimen=1}})
 m   11:51  Prostate cancer‎ (diff | hist) . . (+752). . Jwarner (talk | contribs) (ADT & Enzalutamide {{#subobject:79lq3c|Regimen=1}})
 m   11:46  Response to treatment‎‎ (3 changes | history) . . (+53). . [Jwarner‎ (3×)]
 m    11:46 (cur | prev) . . (+55). . Jwarner (talk | contribs) (Neoadjuvant response rates)
 m    11:46 (cur | prev) . . (-54). . Jwarner (talk | contribs) (Progression-free survival rate at 6 months (PFS6))
 m    11:46 (cur | prev) . . (+52). . Jwarner (talk | contribs) (Relapse-free interval (RFI))
 m   11:42  Bladder cancer‎ (diff | hist) . . (+1,318). . Jwarner (talk | contribs) (Locally advanced or metastatic disease, subsequent lines)

19 August 2019

 m   22:49  Non-small cell lung cancer‎‎ (2 changes | history) . . (+3,041). . [Jwarner‎ (2×)]
 m    22:49 (cur | prev) . . (+1,537). . Jwarner (talk | contribs) (Carboplatin & Gemcitabine {{#subobject:7a8bcz|Regimen=1}})
 m    22:46 (cur | prev) . . (+1,504). . Jwarner (talk | contribs) (Carboplatin & Pemetrexed {{#subobject:920f46|Regimen=1}})
     20:08  NTRK‎ (diff | hist) . . (+1,880). . Jwarner (talk | contribs) (Larotrectinib monotherapy {{#subobject:e0d17a|Regimen=1}})